Beta Bionics BBNX
$13.36 +$0.04 (+0.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.36 0.00%
Open$13.05
Prev close$13.32
Day range$12.92 – $13.85
Volume960.3K
Market cap$726.34M
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±11.3%last 8 reports
Closed higher3 of 838% of the time
Best reaction+26.6%
Worst reaction-16.5%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 27 Oct 2026 | After Market | ±21.7% | -16.55% | Within range |
| 2026/Q2 | 29 Jul 2026 | After Market | ±24.2% | -5.93% | Within range |
| 2026/Q1 | 21 Apr 2026 | After Market | ±39.9% | -0.57% | Within range |
| 2025/Q4 | 17 Feb 2026 | After Market | ±15.6% | -2.58% | Within range |
| 2025/Q3 | 28 Oct 2025 | After Market | – | +10.34% | – |
| 2025/Q2 | 29 Jul 2025 | After Market | – | +14.32% | – |
| 2025/Q1 | 6 May 2025 | After Market | – | +26.61% | – |
| 2024/Q4 | 25 Mar 2025 | After Market | – | -13.60% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$35.51M+30.3% YoY
Operating profit-$26.61M-56.1% YoY
Net profit-$24.35M-71.4% YoY
Diluted EPS-$0.52-57.6% YoY
Free cash flow-$14.56M-45.5% YoY
Operating cash flow-$12.29M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin58.6%
Operating margin-72.7%
Net margin-65.3%
Return on equity-23.9%
Return on assets-21.5%
Return on invested capital-26.1%
Current ratio8.92
Liabilities / assets9.5%
Cash & investments$240.20M
Total debt$4.65M
Net cash (debt)$235.56M
No comments yet — be the first to weigh in on BBNX.
Sign in to join the discussion.